JP2021533167A5 - - Google Patents

Info

Publication number
JP2021533167A5
JP2021533167A5 JP2021506506A JP2021506506A JP2021533167A5 JP 2021533167 A5 JP2021533167 A5 JP 2021533167A5 JP 2021506506 A JP2021506506 A JP 2021506506A JP 2021506506 A JP2021506506 A JP 2021506506A JP 2021533167 A5 JP2021533167 A5 JP 2021533167A5
Authority
JP
Japan
Prior art keywords
acid sequence
amino acid
seq
fusion antibody
antibody according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021506506A
Other languages
English (en)
Japanese (ja)
Other versions
JP7532338B2 (ja
JP2021533167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045547 external-priority patent/WO2020033577A2/en
Publication of JP2021533167A publication Critical patent/JP2021533167A/ja
Publication of JP2021533167A5 publication Critical patent/JP2021533167A5/ja
Priority to JP2024124266A priority Critical patent/JP2024153824A/ja
Application granted granted Critical
Publication of JP7532338B2 publication Critical patent/JP7532338B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506506A 2018-08-07 2019-08-07 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物 Active JP7532338B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024124266A JP2024153824A (ja) 2018-08-07 2024-07-31 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862715693P 2018-08-07 2018-08-07
US201862715697P 2018-08-07 2018-08-07
US201862715696P 2018-08-07 2018-08-07
US62/715,693 2018-08-07
US62/715,696 2018-08-07
US62/715,697 2018-08-07
PCT/US2019/045547 WO2020033577A2 (en) 2018-08-07 2019-08-07 Methods and compositions for increasing the activity in the cns of hexosaminidase a, acid sphingomyelinase, and palmitoyl-protein thioesterase 1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024124266A Division JP2024153824A (ja) 2018-08-07 2024-07-31 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物

Publications (3)

Publication Number Publication Date
JP2021533167A JP2021533167A (ja) 2021-12-02
JP2021533167A5 true JP2021533167A5 (https=) 2022-08-10
JP7532338B2 JP7532338B2 (ja) 2024-08-13

Family

ID=69415150

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506506A Active JP7532338B2 (ja) 2018-08-07 2019-08-07 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物
JP2024124266A Pending JP2024153824A (ja) 2018-08-07 2024-07-31 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024124266A Pending JP2024153824A (ja) 2018-08-07 2024-07-31 ヘキソサミニダーゼａ、酸スフィンゴミエリナーゼおよびパルミトイル－タンパク質チオエステラーゼ１のｃｎｓにおける活性を増加させるための方法および組成物

Country Status (6)

Country Link
US (1) US20240252667A1 (https=)
EP (1) EP3833689A4 (https=)
JP (2) JP7532338B2 (https=)
AU (1) AU2019317460A1 (https=)
CA (1) CA3107749A1 (https=)
WO (1) WO2020033577A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2485761B1 (en) 2009-10-09 2019-02-27 Armagen, Inc. Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
KR20250161626A (ko) * 2023-03-20 2025-11-17 스파크 테라퓨틱스, 인코포레이티드 Ppt1 유전자 치료

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050142141A1 (en) * 2002-11-27 2005-06-30 Pardridge William M. Delivery of enzymes to the brain
US8053569B2 (en) 2005-10-07 2011-11-08 Armagen Technologies, Inc. Nucleic acids encoding and methods of producing fusion proteins
IL193282A (en) * 2006-02-06 2013-04-30 Yeda Res & Dev Chimeric protein of therapeutic enzyme and granulocyte-stimulating factor for treatment of lysosomal storage diseases
CA2641070C (en) * 2006-02-06 2017-01-03 Ramot At Tel-Aviv University Ltd. Enzyme replacement therapy for treating lysosomal storage diseases
AU2008282496B2 (en) 2007-07-27 2013-04-04 Armagen Technologies, Inc. Methods and compositions for increasing alpha-iduronidase activity in the CNS
EP2485761B1 (en) 2009-10-09 2019-02-27 Armagen, Inc. Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
AU2012346448B2 (en) 2011-12-02 2017-09-14 Armagen, Inc. Methods and compositions for increasing arylsulfatase A activity in the CNS
CA2888628A1 (en) * 2012-10-19 2014-04-24 Tokushima University Novel high functional enzyme having modified substrate specificity of human beta-hexosaminidase b and exhibiting protease resistance
JP6692293B2 (ja) 2013-07-22 2020-05-13 アーマジェン・インコーポレイテッドＡｒｍａｇｅｎ， Ｉｎｃ． Ｃｎｓにおける酵素活性を増大するための方法および組成物
WO2015150922A2 (en) * 2014-03-17 2015-10-08 The Hospital For Sick Children β-HEXOSAMINIDASE PROTEIN VARIANTS AND ASSOCIATED METHODS FOR TREATING GM2 GANGLIOSIDOSES
US10538589B2 (en) * 2015-01-14 2020-01-21 Armagen Inc. Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE

Similar Documents

Publication Publication Date Title
JP6721590B2 (ja) 多重特異性抗体
AU2009201466B2 (en) Multimeric proteins and methods of making and using same
CN112409480B (zh) 结合血清白蛋白的蛋白及其用途
CN114450406B (zh) 一种断裂型内含肽、使用其的重组多肽的制备方法
JP2020506898A5 (https=)
JP2009523459A5 (https=)
EP3579875B1 (en) Anti human annexin a1 antibody
JP2023502968A5 (https=)
JP2016525545A5 (https=)
JP2013515508A5 (https=)
CA3158206A1 (en) Modified immunoglobulins for targeting amyloid deposits cross-reference to related applications
AU2024201813A1 (en) Blood-brain barrier transmigrating compounds and uses thereof
WO2023186120A1 (zh) 抗血清白蛋白纳米抗体及其衍生物
CA3118640A1 (en) Single domain antibodies that bind human serum albumin
JP2022505445A5 (https=)
CA3136598A1 (en) Binding molecules
RS55133B1 (sr) Antigen vezujući proteini specifični za p komponentu amiloida seruma
JP2021533167A5 (https=)
JP2022516660A5 (https=)
JP2024506020A5 (https=)
US20240092905A1 (en) Dna therapeutic encoding an antibody or antigen binding fragment
IL317895A (en) Anti-SARS-COV-2 antigen-binding polypeptides, polypeptide complexes and methods of using them
JP2025506341A5 (https=)
CA3232365A1 (en) Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof in hiv
US20260042865A1 (en) Multispecific molecules for clearance of immunoglobulins in the treatment of autoantibody-induced diseases